United Kingdom: MHRA

Document control and traceability for MHRA and UKCA submissions

For medical device teams placing devices on the Great Britain market. Keep the design controls, risk file and verification evidence the UK MDR 2002 expects linked and controlled, so the technical documentation is current when a UK Approved Body or the MHRA asks for it.

See medical device featuresBook a demo

The MHRA regulates medical devices in the UK, and in Great Britain the law is the Medical Devices Regulations 2002 (UK MDR 2002). Placing a device on that market means conformity assessment, UKCA or recognised CE marking, MHRA registration and post-market surveillance. Traceable keeps the documents and trace links behind that evidence controlled.

What the MHRA expects, and where Traceable helps

UK medical device requirements and where Traceable helps with the documentation for each
AreaWhat it asks of a manufacturerWhere Traceable helps
UK MDR 2002Devices placed on the Great Britain market meet the essential requirements of the Medical Devices Regulations 2002, shown through a conformity assessment for the device’s class.Requirements, risks and tests are structured rows with TraceIDs, so the evidence for each requirement is linked to it rather than collected by hand.
UKCA markingA UKCA mark for the Great Britain market. Where the class needs third-party assessment, a UK Approved Body reviews the technical documentation.Controlled documents publish with a locked PDF snapshot, e-signatures and a revision table, so the version a reviewer assessed is the version you can produce.
Registration and UKRPDevices registered with the MHRA before they are placed on the market. A manufacturer based outside the UK appoints a UK Responsible Person.Traceable does not register devices or act for you. It keeps the device description, intended purpose and labelling documents your registration draws on under control.
Post-market surveillanceSince 16 June 2025, a post-market surveillance plan, periodic reports, and shorter timelines for reporting serious incidents.Impact alerts flag every document that traces to one republished with changes, so a design change driven by post-market data reaches the risk file and tests.

Great Britain, Northern Ireland, and two marks

The UK has two device regimes. In Great Britain (England, Wales and Scotland), devices are regulated under the UK MDR 2002, and the conformity mark is UKCA. Northern Ireland follows the EU Medical Devices Regulation and In Vitro Diagnostic Regulation, and the UKCA mark is not recognised there or in the EU. The MHRA is the regulator for both.

CE marked devices are currently accepted on the Great Britain market under transitional arrangements. The government has consulted on recognising CE marked devices indefinitely, and has said manufacturers would still need a UK Responsible Person, MHRA registration and to meet GB post-market surveillance duties. These arrangements have changed several times, so check the MHRA's guidance on regulating medical devices in the UK for the position that applies to your device today.

What changed in June 2025

The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 came into force on 16 June 2025. They add a new Part 4A to the UK MDR 2002 and, in the MHRA's summary, bring a required post-market surveillance plan, periodic summary reports, and shorter timelines for reporting serious incidents. Manufacturers must also be able to give the MHRA their post-market surveillance report or periodic safety update report within three working days of a request.

That last point is a document control problem as much as a surveillance one. A report has to be the current, approved version, findable in minutes, with a record of who approved it. In Traceable a published document is a locked PDF snapshot with its signatures and revision table, so the approved version is the one you send.

Design controls, traceability and document control in one place

Document control

Review gated on resolved comments, e-signatures with the signer, role and time, and a locked snapshot at every publish. Our ISO 13485 document control guide covers what clauses 4.2.4 and 4.2.5 expect.

Design controls

Lay out design inputs, outputs, verification, validation and transfer on the project plan, and keep the design history file current as you go rather than assembling it before an audit.

Traceability

Trace user needs to requirements to tests in a live traceability matrix, with broken links flagged. See our guide to the traceability matrix for medical devices.

Risk management

Build the hazard analysis as an ID grid with severity, occurrence and a computed rating, linked to the controls and tests. Our ISO 14971 guide explains the process.

Software life cycle

For software that is a medical device, start from templates aligned with IEC 62304. Read the IEC 62304 guide and use the free IEC 62304 checklist.

Start from what you have

Import existing Word and Excel documents, or begin from the free traceability matrix template.

What Traceable does not do

Traceable is documentation software. It does not register devices with the MHRA, act as your UK Responsible Person, report incidents, decide your device's classification or carry out conformity assessment, and it is not approved or endorsed by the MHRA. It keeps the documents those steps depend on controlled and traced, so the evidence is ready when they happen.

Teams selling into more than one market can read the EU MDR and HPRA page for Ireland and the EU, and the HSA page for Singapore.

Common questions

Is Traceable approved by the MHRA?

No. The MHRA regulates medical devices, not the software a manufacturer uses to write its documentation. Traceable helps you produce, control and trace the documentation the UK MDR 2002 expects. Conformity, UKCA marking and registration remain the manufacturer’s responsibility.

Does Traceable work for CE marked and UKCA marked devices at the same time?

Yes. The design controls, risk file and verification evidence behind a device are largely shared between markets. Traceable keeps one traced set of documents, and you can branch or clone a document where a market needs its own version.

Can Traceable help with the new GB post-market surveillance rules?

It helps with the documentation side. A post-market surveillance plan and its reports can be controlled documents with review and e-signatures, and impact alerts show which traced documents a change affects. Reporting incidents to the MHRA is done through the MHRA’s own systems.

Is our medical device software regulated by the MHRA?

Software with a medical purpose can be a medical device under the UK MDR 2002. The MHRA publishes guidance on stand-alone software and apps, and qualification turns on the intended purpose. Traceable is not a medical device and makes no qualification decision for you.

See your UK technical documentation traced

Import your existing requirements and risk files, and see live coverage in minutes.

Start free